The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

PDF) Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment—A

Oncogenic driver mutations in non-small cell lung cancer: Past

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

非小细胞肺癌治疗新靶点_医学界-助力医生临床决策和职业成长

Uncommon Oncogenic Drivers in NSCLC - (ILCN/WCLC)

Frontiers Recent progress in targeted therapy for non-small cell

IJMS, Free Full-Text

Biomolecules, Free Full-Text

Frontiers Anaplastic lymphoma kinase inhibitors—a review of anticancer properties, clinical efficacy, and resistance mechanisms

Electropherogram showing Sanger sequencing of the CLIP1-LTK fusion

SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers

Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver

PDF) ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers